Lotus CR LLC | Pain CRO & Clinical Trial Consultants

CRO Services

A scientifically-driven CRO for your Pain and CNS investigations.

Project Management
EDC & Data Management
Site Selection
Biostatistics
Medical Monitoring

Scientific Services

Specialized education and training for accurate results and outcomes.

Placebo Response Videos
Maximizing Effect Size
Rater Training
Staff Training
Subject Education

News & Press

Neil Singla, MD- Public Comments on FDA’s February 2022 Draft Guidance for Industry

The draft guidance document can be found here. April 8, 2022 RE: Development of Non-Opioid Analgesics for Acute Pain: Guidance for Industry; Draft Date February

April 20, 2022

Press Release: Innocoll Biotherapeutics plc Announces First Patients In Phase 3 Clinical Trials for Label Expansion of Xaracoll® (bupivacaine hydrochloride) Implant

Lotus Clinical Research worked closely with Innocoll on the design of both new Phase 3 trials, and is currently conducting both studies within our CRO

May 25, 2021

Press Release: Concentric Analgesics Announces Positive Topline Results from Phase 2 Clinical Trial of Vocacapsaicin (CA-008) in Total Knee Arthroplasty Surgery

Lotus Clinical Research has worked with Concentric for several years and through multiple studies on their novel non-opioid analgesic vocacapsaicin. Recently, Lotus CRO has been

May 25, 2021

We are a specialty analgesic CRO and site that supports all phases of
discovery for novel analgesics. We provide scientific leadership and
have extensive experience with the analgesic approval process.

ANALGESIC DRUG APPROVALS

350+

PAIN TRIALS COMPLETED

POSITIVE FDA AUDITS AND NO 483S ISSUED

Learn More About Who We Are

Better Science. Superior Results.